Evaluation of Treatment of Fractures of the Humerus With a Plate.
Evaluation of the Winsta PH Osteosynthesis Device in the Treatment of Three- and Four-Part Fractures of the Proximal Humerus A Prospective Migration and Bone Density Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
We shall measure the following clinical parameters with the help of the Constant Shoulder Score (CSS) and Western Ontario Osteoarthritis of the Shoulder Index (WOOS):
- Pain
- Activities of Daily Living (ADL)
- Range of Motion (ROM)
- Muscle strength
We shall measure the following radiologic parameters:
- Healing (migration) of tuberculum majus and minus measured with use of MB-RSA
- Plate migration with use of MB-RSA
- Bone density in the proximal humerus measured with Dual Energy X-ray Absorptiometry (DEXA)
- Correlation between bone density and prosthesis migration (and tuberculum migration)
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Inger B Mechlenburg, MSc
- Phone Number: +45 65371093
- Email: inger.mechlenburg@ki.au.dk
Study Contact Backup
- Name: Maiken Stilling, MD
- Phone Number: +45 89 49 74 66
- Email: maiken.stilling@ki.au.dk
Study Locations
-
-
-
Silkeborg, Denmark, 8600
- Orthopaedic Department K, Silkeborg Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with three-part and four-part proximal humeral fractures
- Aged 50 years or older and fit
- Informed, written consent
- A functioning shoulder preoperatively -
Exclusion Criteria:
- Patients found unsuitable preoperatively for a shoulder Philos Plate
- Patients aged 85 or older
- Patients with rheumatoid arthritis
- Patients who previously had undergone shoulder plastic or other major shoulder surgery
- Patients unable to avoid NSAID after surgery
- Patients requiring regular systemic steroid treatment
- Female patients taking hormone substitution
- Female patients in the fertile age range who do not use safe anti-conception (oral contraception, intrauterine devices, depot gestagens, vaginal hormone rings)
- Patients with metabolic bone disease -
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
1
Winsta PH osteosynthesis device (Fischer Medical)for treatment of humeral fracture
|
The Winsta PH osteosynthesis device have been developed for use in treatment of proximal humerus fractures.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Healing (migration) of tuberculum majus and minus measured with use of Model-Based Roentgen Stereophotogrammetric Analysis (MB-RSA)
Time Frame: five years
|
Migration of the tubercles measured with Model-Based Roentgen Stereophotogrammetric Analysis (MB-RSA)
|
five years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Correlation between bone density and prosthesis migration (and tuberculum migration)
Time Frame: five years
|
five years
|
|
Range of Motion (ROM)
Time Frame: five years
|
five years
|
|
Muscle strength
Time Frame: five years
|
five years
|
|
Activities of Daily Living (ADL)
Time Frame: five years
|
five years
|
|
Bone density in the proximal humerus measured with Dual Energy X-ray Absorptiometry (DEXA)
Time Frame: five years
|
five years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Kjeld Soballe, Professor, Orthopaedic Department, Aarhus University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 20060166
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.